RT info:eu-repo/semantics/article
T1 mHealth intervention to improve quality of life in patients with chronic diseases during the COVID-19 crisis in Paraguay : a study protocol for a randomized controlled trial
A1 Escrivá Martínez, Tamara
A1 Vara, María Dolores
A1 Czeraniuk de Schaefer, Nadia
A1 Denis Cácaro, Matías
A1 Núñez Benjumea, Francisco J.
A1 Fernández Luque, Luis
A1 Jiménez Díaz, Alba
A1 Traver Saucedo, Vicente
A1 Lull Noguera, Juan José
A1 Martínez Millana, Antonio
A1 Garcés Ferrer, Jorge
A1 Miragall, Marta
A1 Herrero, Rocío
A1 Enríquez Tischler, Analía Soledad
A1 Schaefer Czeraniuk, Laura Verena
A1 Cervera Torres, Sergio
A1 Villasanti Riquelme, Cecilia Beatriz
A1 Cabral, Carmen Verónica
A1 Fernández, Irene
A1 Baños Rivera, Rosa María
A2 Universidad Autónoma de Encarnación
AB Background. Patients with chronic disease represent an at-risk group in the face of the COVID-19 crisis as they need to regularly monitor their lifestyle and emotional management. Coping with the illness becomes a challenge due to supply problems and lack of access to health care facilities. It is expected these limitations, along with lockdown and social distancing measures, have affected the routine disease management of these patients, being more pronounced in low- and middle-income countries with a flawed health care system.Objectives. The purpose of this study is to describe a protocol for a randomized controlled trial to test the efficacy of the Adhera® MejoraCare Digital Program, an mHealth intervention aimed at improving the quality of life of patients with chronic diseases during the COVID-19 outbreak in Paraguay.Method. A two-arm randomized controlled trial will be carried out, with repeated measures (baseline, 1-month, 3-month, 6-month, and 12-month) under two conditions: Adhera® MejoraCare Digital Program or waiting list. The primary outcome is a change in the quality of life on the EuroQol 5-Dimensions 3-Levels Questionnaire (EQ-5D-3L). Other secondary outcomes, as the effect on anxiety and health empowerment, will be considered. All participants must be 18 years of age or older and meet the criteria for chronic disease. A total of 96 participants will be recruited (48 per arm).Conclusions. It is expected that the Adhera® MejoraCare Digital Program will show significant improvements in quality of life and emotional distress compared to the waiting list condition. Additionally, it is hypothesized that this intervention will be positively evaluated by the participants in terms of usability and satisfaction. The findings will provide new insights into the viability and efficacy of mHealth solutions for chronic disease management in developing countries and in times of pandemic.Trial registration. ClinicalTrials.gov NCT04659746.
PB Public Library of Science
YR 2022
FD 2022-11-08
LK http://hdl.handle.net/20.500.14066/4723
UL http://hdl.handle.net/20.500.14066/4723
LA eng
NO Escrivá-Martínez, T., Vara, M. D., Czaraniuk, N., Denis, M., Núñez-Benjumea, F. J., Fernández-Luque, L., Jiménez-Díaz, A., Traver, V., Llull, J. J., Martínez-Millana, A., Garcés-Ferrer, J., Miragall, M., Herrero, R., Enríquez, A., Schaefer, V., Cervera-Torres, S., Villasanti, C., Cabral, C. V., Fernández, I., & Baños, R. M. (2022). mHealth intervention to improve quality of life in patients with chronic diseases during the COVID-19 crisis in Paraguay: a study protocol for a randomized controlled trial. PLOS ONE, 17(11), Article e0273290. https://doi.org/10.1371/journal.pone.0273290
NO Correspondencia a los autores: tamara.escriva@uv.es.
NO Trial registration. ClinicalTrials.gov NCT04659746. Enlace: https://clinicaltrials.gov/study/NCT04659746?tab=table.
NO Consejo Nacional de Ciencia y Tecnología
DS MINDS@UW
RD 03-sep-2026